Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q2 2026 vs. Q1 2026
How the institutions holding Mesoblast Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 69 | 72 | +3 |
| Shares | 3.29M | 3.87M | +581.8K (+17.7%) |
| Value | $50.5M | $53.3M | +$2.76M (+5.5%) |
New holders (9)
Institutions that held Mesoblast Ltd at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 259,700 | $3.51M | 0.00% |
| R Squared Ltd | 14,492 | $196.1K | 0.10% |
| Ballentine Partners, LLC | 10,448 | $141.4K | 0.00% |
| Simplex Trading, LLC | 6,971 | $94.3K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 2,338 | $31.6K | 0.00% |
| IFG Advisory, LLC | 750 | $10.1K | 0.00% |
| The PNC Financial Services Group, Inc. | 147 | $1.99K | 0.00% |
| Stone House Investment Management, LLC | 23 | $311 | 0.00% |
| Russell Investments Group, Ltd. | 1 | $14 | 0.00% |
Sold out (6)
Institutions that held Mesoblast Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Citadel Advisors LLC | 85,959 | $1.32M |
| HRT Financial LP | 34,223 | $526.0K |
| Quadrant Capital Group LLC | 6,647 | $102.2K |
| JFS Wealth Advisors, LLC | 3,335 | $51.3K |
| Advisory Services Network, LLC | 475 | $7.31K |
| MAI Capital Management | 50 | $769 |